SCHEMBL6889005

SCHEMBL6889005

CCOC(=O)c1cc([N+](=O)[O-])no1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.43
ALDH1A1 P00352 4/20 0.41
LMNA P02545 3/20 0.41
MITF O75030 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
POLB P06746 2/20 0.41
GALR2 O43603 1/20 0.41
HSP90AA1 P07900 1/20 0.41
HPGD P15428 1/20 0.41
XBP1 P17861 1/20 0.41
CCR6 P51684 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
GSTP1 P09211 2/20 0.40
GSTM2 P28161 2/20 0.40
RAB9A P51151 2/20 0.40
GAA P10253 1/20 0.40
KMT2A Q03164 2/20 0.39
MAPT P10636 5/20 0.39
PKM P14618 1/20 0.39
CRHBP P24387 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6889201 0.83 LMNA (0.39) NPC1ALDH1A1LMNASMN1; SMN2POLB
SCHEMBL2296719 0.77 RAB9A (0.54) LMNASMN1; SMN2POLBRAB9AGAA
SCHEMBL1800827 0.77 HCAR2 (0.58) NPC1ALDH1A1LMNAPOLBRAB9A
SCHEMBL6883982 0.77 MAPK1 (0.36) NPC1ALDH1A1LMNARAB9AKMT2A
SCHEMBL9454253 0.76 CA12 (0.46) NPC1ALDH1A1LMNASMN1; SMN2RAB9A
SCHEMBL368680 0.74 ALDH1A1 (0.43) NPC1ALDH1A1LMNASMN1; SMN2POLB
SCHEMBL31124057 0.74 MAPT (0.49) NPC1ALDH1A1LMNAPOLBHPGD
SCHEMBL2184554 0.74 GAA (0.44) NPC1ALDH1A1LMNASMN1; SMN2HPGD
SCHEMBL21159080 0.74 LMNA (0.43) NPC1ALDH1A1LMNAPOLBRAB9A
SCHEMBL14770789 0.74 RAB9A (0.45) NPC1ALDH1A1LMNASMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6835842-B2 Microbiocides; bactericides BAYER AKTIENGESELLSCHAFT (DE) 2004-12-28 US claimed
US-20030207929-A1 3-nitroisoxazoles and their use in the protection of materials LANXESS DEUTSCHLAND GMBH (DE) 2003-11-06 US claimed
US-20030166698-A1 3-NITROISOXAZOLES AND THEIR USE IN THE PROTECTION OF MATERIALS LANXESS DEUTSCHLAND GMBH (DE) 2003-09-04 US claimed
US-6835842-B2 Microbiocides; bactericides BAYER AKTIENGESELLSCHAFT (DE) 2004-12-28 US disclosed
US-20030207929-A1 3-nitroisoxazoles and their use in the protection of materials LANXESS DEUTSCHLAND GMBH (DE) 2003-11-06 US disclosed
US-6638958-B2 3-nitroisoxazoles and their use in the protection of materials BAYER AKTIENGESELLSCHAFT (DE) 2003-10-28 US disclosed
US-20030166698-A1 3-NITROISOXAZOLES AND THEIR USE IN THE PROTECTION OF MATERIALS LANXESS DEUTSCHLAND GMBH (DE) 2003-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166698-A1 3-NITROISOXAZOLES AND THEIR USE IN THE PROTECTION OF MATERIALS GPX1, NOX1, XDH NPC1 1665/4885ALDH1A1 99/4885LMNA 1036/4885
US-20030207929-A1 3-nitroisoxazoles and their use in the protection of materials GPX1, NOX1, XDH NPC1 1665/4885ALDH1A1 99/4885LMNA 1036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.